ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds

June 18, 1976

Clinical Trials Renew By NCI Gets Under Way

May 3, 1985

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989

DRCCA Board Okays Chemoprevention RFA, Referral Guidelines

January 29, 1982

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997